Methods for treating B-cell malignancies using TACI-Ig fusion molecule

Details for Australian Patent Application No. 2006278229 (hide)

Owner Ares Trading S.A. Mayo Foundation for Medical Education and Research ZymoGenetics, Inc.

Inventors Sievers, Eric; Ansell, Stephen M.; Busby, Sharon J.; Ythier, Arnaud; Ohrstrom, Jan; Broly, Herve; Nestorov, Ivan

Agent FB Rice

Pub. Number AU-B-2006278229

PCT Pub. Number WO2007/019575

Priority 60/706,912 09.08.05 US

Filing date 9 August 2006

Wipo publication date 15 February 2007

Acceptance publication date 27 October 2011

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 February 2008 PCT application entered the National Phase

  PCT publication WO2007/019575 Priority application(s): WO2007/019575

27 October 2011 Application Accepted

  Published as AU-B-2006278229

23 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006278232-Tumescent skin spacing method

2006278227-Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules